all report title image

Calcineurin Inhibitor Market, By Drug Type (Cyclosporine, Tacrolimus, Pimecrolimus, Voclosporin, and Others), By Route of Administration (Oral, Topical, and Intravenous), By Indication (Organ Transplant Rejection Prevention, Autoimmune Diseases, Ophthalmic Diseases (Dry Eye Syndrome, Uvei, Other Dermatological Conditions), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Specialty Clinics, Dermatology Centers, Transplant Centers), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

  • Published In : Nov 2023
  • Code : CMI5848
  • Pages :130
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Calcineurin Inhibitor, By Drug Type
      • Market Calcineurin Inhibitor, By Route of Administration
      • Market Calcineurin Inhibitor, By Indication
      • Market Calcineurin Inhibitor, By Distribution Channel
      • Market Calcineurin Inhibitor, By End User
      • Market Calcineurin Inhibitor, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Calcineurin Inhibitor Market– Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Global Calcineurin Inhibitor Market, By Drug Type, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2023 – 2030
      • Segment Trends
    • Cyclosporine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    •  Tacrolimus
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Pimecrolimus
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Voclosporin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  6. Global Calcineurin Inhibitor Market, By Route of Administration, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019– 2030
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  7. Global Calcineurin Inhibitor Market, By Indication, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019– 2030
      • Segment Trends
    • Organ Transplant Rejection Prevention
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Autoimmune Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Ophthalmic Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Other Dermatological Conditions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  8. Global Calcineurin Inhibitor Market, By Distribution Channel, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019– 2030
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  9. Global Calcineurin Inhibitor Market, By End User, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023and 2030 (%)
      • Y-o-Y Growth Analysis, 2019– 2030
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Dermatology Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Transplant Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  10. Global Calcineurin Inhibitor Market, By Region, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, By Region, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Region, 2019 – 2030
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
        • South Africa
        • North Africa
        • Central Africa
  11. Competitive Landscape
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Incyte Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Chiesi Farmaceutici S.p.A.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Astellas Pharma Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi SA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bristol Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mylan N.V.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Reddy's Laboratories Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Senju Pharmaceutical Co. Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Abbott
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Lupin Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Vibcare Pharma Pvt. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  12. Section
    • Research Methodology
    • About us

*Browse 60 market data tables and 45 figures on "Global Calcineurin Inhibitor Market” - Global forecast to 2030

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.